全文获取类型
收费全文 | 7124篇 |
免费 | 378篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 119篇 |
儿科学 | 425篇 |
妇产科学 | 77篇 |
基础医学 | 766篇 |
口腔科学 | 142篇 |
临床医学 | 513篇 |
内科学 | 1449篇 |
皮肤病学 | 237篇 |
神经病学 | 394篇 |
特种医学 | 123篇 |
外科学 | 1103篇 |
综合类 | 204篇 |
一般理论 | 1篇 |
预防医学 | 324篇 |
眼科学 | 221篇 |
药学 | 657篇 |
1篇 | |
中国医学 | 32篇 |
肿瘤学 | 738篇 |
出版年
2023年 | 44篇 |
2022年 | 119篇 |
2021年 | 255篇 |
2020年 | 126篇 |
2019年 | 189篇 |
2018年 | 230篇 |
2017年 | 150篇 |
2016年 | 219篇 |
2015年 | 235篇 |
2014年 | 323篇 |
2013年 | 387篇 |
2012年 | 594篇 |
2011年 | 624篇 |
2010年 | 348篇 |
2009年 | 268篇 |
2008年 | 434篇 |
2007年 | 404篇 |
2006年 | 397篇 |
2005年 | 357篇 |
2004年 | 331篇 |
2003年 | 301篇 |
2002年 | 260篇 |
2001年 | 66篇 |
2000年 | 71篇 |
1999年 | 78篇 |
1998年 | 45篇 |
1997年 | 27篇 |
1996年 | 33篇 |
1995年 | 16篇 |
1994年 | 24篇 |
1993年 | 16篇 |
1992年 | 33篇 |
1991年 | 22篇 |
1990年 | 35篇 |
1989年 | 38篇 |
1988年 | 42篇 |
1987年 | 33篇 |
1986年 | 32篇 |
1985年 | 33篇 |
1984年 | 27篇 |
1983年 | 27篇 |
1979年 | 24篇 |
1977年 | 13篇 |
1974年 | 22篇 |
1972年 | 16篇 |
1971年 | 17篇 |
1970年 | 13篇 |
1969年 | 11篇 |
1968年 | 16篇 |
1967年 | 15篇 |
排序方式: 共有7526条查询结果,搜索用时 15 毫秒
991.
Mice deficient in biglycan and fibromodulin as a model for temporomandibular joint osteoarthritis 总被引:1,自引:0,他引:1
The temporomandibular joint (TMJ) within the craniofacial complex is unique. In humans, the TMJ can become diseased resulting in severe and disabling pain. There are no cures for TMJ disease at this time. Animal models of TMJ disease are scarce, but some exist, and they are described in this paper. We present in greater detail one animal model that is deficient in two extracellular matrix (ECM) proteoglycans, biglycan (BGN) and fibromodulin (FMOD). Doubly deficient BGN/FMOD mice develop premature TMJ osteoarthritis (OA). In order to explore the mechanistic basis of TMJ-OA, tissues from the condyle of mutant mice were examined for their relative capacity to differentiate and undergo apoptosis. Our data show that there is a redistribution of the critical ECM protein, type II collagen, in mutant mice compared with controls. Mutant mice also have increased apoptosis of the chondrocytes embedded in the articular cartilage. We speculate that the overall imbalance in apoptosis may be the cellular basis for the abnormal production of structural ECM proteins. The abnormal production of the ECM could, in turn, lead to premature erosion and degradation of the articular surface resulting in TMJ-OA. These data underscore the importance of the ECM in controlling the structural integrity of the TMJ. 相似文献
992.
993.
Diagnosing tubercular pleural effusions 总被引:1,自引:0,他引:1
994.
STUDY OBJECTIVES: Inhaled, short-acting beta-agonists and systemic corticosteroids form the mainstay of therapy in acute asthma exacerbation. Asthma, however, is an inflammatory disease of the airways, and its underlying pathology is not impacted by short-acting beta-agonists. While the efficacy of ad-lib beta-agonist administration in outpatient management of asthma symptoms is well established, little data exist to support this strategy in patients with acute, severe asthma. We postulate that as long as patients hospitalized with severe asthma exacerbation receive systemic corticosteroids, regular, scheduled administration of short-acting beta-agonists is unnecessary. Similar therapeutic outcomes can be achieved with the ad-lib administration of the short-acting beta-agonists. DESIGN: Prospective, randomized, double-blind, placebo-controlled trial. SETTING: Pulmonary floor of a 600-bed municipal hospital.Patients or participants: Sixty-two patients hospitalized for acute asthma. INTERVENTIONS: Patients were randomized to receive either albuterol nebulizations (regular albuterol group) or saline solution nebulizations (ad-lib group) every 4 h with management of breakthrough symptoms with albuterol metered-dose inhaler or nebulizations for both groups. All patients received systemic corticosteroids. Peak expiratory flows, asthma symptoms, and need for rescue bronchodilator were followed up on each patient until discharge. RESULTS: There was no significant difference in the length of hospitalization (median length, 48 h for ad-lib group vs 57.5 h for regular albuterol group, p = 0.82), rate of improvement in peak flow, or symptoms between the two groups. Ad-lib beta-agonist use compared to regular albuterol scheduled use resulted in a significant reduction in the total number of albuterol treatments administered (median, 7 treatments vs 19 treatments, p = 0.001) during hospitalization. CONCLUSIONS: In the management of asthma exacerbation, ad-lib administration of albuterol is therapeutically as effective as regular, scheduled administration. This method of drug administration also reduces the total dose of beta-agonists received by the hospitalized patient. 相似文献
995.
For patients with renal artery stenosis, percutaneous transluminal angioplasty is generally the treatment of choice. This report describes the case of an elderly lady with type III aortoarteritis whose right renal artery was successfully recalized and stented. There was satisfactory improvement in renal function and blood pressure post-procedure, and at one-month follow-up. 相似文献
996.
A short cut review was carried out to establish whether primary split skin grafting is better than simple wound edge approximation at reducing time to healing in patients with pretibial flap lacerations. A total of 72 papers were found using the reported search, of which one presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of this best paper are tabulated. A clinical bottom line is stated. 相似文献
997.
Platelet adhesion in hypertension: application of a novel assay of platelet adhesion 总被引:4,自引:0,他引:4
BACKGROUND: The increased risk of thromboembolism in hypertension may be related to a prothrombotic or hypercoagulable state, with abnormalities in haemostasis and platelet function. OBJECTIVE: To investigate the role of platelets in the pathogenesis of thrombosis in hypertension, we applied a novel new assay to detect and quantify the degree of platelet adhesion to a defined coagulation molecule. PATIENTS AND METHODS: Platelet-rich plasma (PRP) and citrated plasma (CP) were obtained from 50 patients with hypertension (25 treated, and 25 untreated) and 30 healthy controls. A suspension of 2 x 10(7) platelets were incubated for one hour in microtitre plates pre-coated with 5mg/mL fibrinogen. The supernatant was carefully aspirated, lysed with 5% tween and stored at -70 degrees C as supernatant platelet lysate (SPL). The wells were carefully washed with saline and bound platelets lysed as before, and stored at -70 degrees C as bound-platelet lysate (BPL). Soluble P-selectin (sP-sel) was determined in CP, SPL and BPL by enzyme-linked immunosorbent assay (ELISA). RESULTS: Patients with hypertension (both treated and previously untreated) had increased platelet adhesion, as determined by increased lysate sP-sel (P=0.002) in BPL, with no change in SPL (P=0.5) compared to healthy controls. There was no significant difference between treated and previously untreated hypertensives. CONCLUSION: Platelets from patients with hypertension display increased adhesion to an important coagulation factor (fibrinogen). This may, in part, account for the increased risk of thrombosis seen in these patients. 相似文献
998.
999.
1000.
Rao RD Krishnan S Fitch TR Schomberg PJ Dinapoli RP Nordstrom K Scheithauer B O'Fallon JR Maurer MJ Buckner JC 《International journal of radiation oncology, biology, physics》2005,61(2):380-386
PURPOSE: To evaluate the efficacy of preradiotherapy (RT) chemotherapy with carmustine, cisplatin, and oral etoposide combined with RT in the treatment of newly diagnosed anaplastic astrocytoma. METHODS AND MATERIALS: Therapy consisted of carmustine (40 mg/m(2)/d) on Days 1-3, oral etoposide (50 mg/d) on Days 1-21 and 29-49, and cisplatin (20 mg/m(2)/d i.v.) on Days 1-3 and 29-31. The regimen was repeated every 8 weeks for three cycles, with conventionally fractionated RT (5000 cGy with a 1000-cGy boost) delivered concurrently with the third cycle. RESULTS: A total of 29 patients were enrolled between December 1999 and March 2001. For varying reasons (e.g., progression, refusal, death, or toxicity), only 48% completed the chemotherapy regimen and 76% completed RT. Grade 3-4 toxicities were observed in 14 patients (48%). The primary study endpoint was the 23-month (700-day) survival, the median survival of patients with anaplastic astrocytoma in a previous North Central Cancer Treatment Group trial. To be considered an active treatment, a maximum of 9 patient deaths (of the first 25) were allowed before 700 days. However, 14 patients had died by 700 days after therapy. CONCLUSION: Our results have demonstrated that pre-RT chemotherapy with this regimen is insufficiently active in patients with anaplastic astrocytoma. 相似文献